(Q38254181)

1 September 2017

1 reference

title

The cancer stem cell hypothesis: a guide to potential molecular targets (English)

1 reference

1 September 2017

neoplastic stem cells

1 reference

1

1 reference

1 September 2017

Andrea Alonci

2

1 reference

1 September 2017

Giuseppa Penna

3

1 reference

1 September 2017

Vanessa Innao

4

1 reference

1 September 2017

Demetrio Gerace

5

1 reference

1 September 2017

Francesco Rotondo

6

1 reference

1 September 2017

Caterina Musolino

7

1 reference

1 September 2017

25 September 2014

1 reference

1 September 2017

1 reference

1 September 2017

32

1 reference

1 September 2017

9

1 reference

1 September 2017

470-495

1 reference

Scientific discovery and scientific reputation: the reception of Peyton Rous' discovery of the chicken sarcoma virus

1 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Two genetic hits (more or less) to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A new theory on cancer-inducing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A perspective on nonmutagenic mechanisms in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

JAK2 617V>F positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The molecular biology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer genetics in oncology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A new hypothesis for the cancer mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

"Cancer stem cells"-lessons from Hercules to fight the Hydra

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells: mirage or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Revisiting the concept of cancer stem cells in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Prostate cancer stem/progenitor cells: identification, characterization, and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Gastric cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

21 January 2018

Stem cells and cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Urothelial carcinoma: stem cells on the edge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

First among equals: the cancer cell hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cell: target for anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Recent advances in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cell concepts renew cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells: lessons from leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Module map of stem cell genes guides creation of epithelial cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stemness, cancer and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Thoughts about cancer stem cells in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cells of origin in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Self-renewal of the adult skeletal muscle satellite cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cell wars: regulation of cell survival and proliferation by cell competition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Signal Transduction and the Control of Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Signaling pathways in cancer and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Targeting Notch to target cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Understanding cancer stem cell heterogeneity and plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

In vitro generation of human cells with cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The utility of hedgehog signaling pathway inhibition for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cell and cancer stemloids: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Radiation resistance of breast cancer stem cells: understanding the clinical framework

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Selective targeting of radiation-resistant tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Ionizing radiation induces stemness in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Evolution of cooperation among tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Endothelial cell differentiation of human breast tumour stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Induced pluripotent stem cells and the stability of the differentiated state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Heterogeneity in cancer: cancer stem cells versus clonal evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cell origin of cancer and differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Leukaemia stem cells and the evolution of cancer-stem-cell research.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Understanding the cancer stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification and targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

SP analysis may be used to identify cancer stem cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Enrichment of cancer stem cells based on heterogeneity of invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells as the relevant biomass for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Creating new fluorescent probes for cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

In vivo imaging, tracking, and targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

In vivo trafficking and targeted delivery of magnetically labeled stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Die hard: are cancer stem cells the Bruce Willises of tumor biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cells in the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Generation of breast cancer stem cells through epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Role of microRNAs in the regulation of breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer and the tumor microenvironment: a review of an essential relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Gene expression profiling of the tumor microenvironment during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Co-evolution of tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Lung cancer stem cells: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Adult lung stem cells and their contribution to lung tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Characterization of a side population of cancer cells from human gastrointestinal system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Novel therapeutic target for cancer stem cells in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Heterogeneity and targeting of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Persistence of side population cells with high drug efflux capacity in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of gastric cancer stem cells using the cell surface marker CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

p63 regulates an adhesion programme and cell survival in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Aldehyde dehydrogenase gene superfamily: the 2002 update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells in bladder cancer: a revisited and evolving concept

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Normal and neoplastic urothelial stem cells: getting to the root of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Biomarkers in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The increasing complexity of the cancer stem cell paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Bladder cancer and cancer stem cells: basic science and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Targeting stem cells-clinical implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Detection and characterization of CD133+ cancer stem cells in human solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of cancer stem cells in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of cells initiating human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Recent advances in cancer stem cell research for cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Isolation of tumour stem-like cells from benign tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Concise review: Emerging concepts in clinical targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cell-directed therapies: recent data from the laboratory and clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Selective elimination of leukemia stem cells: hitting a moving target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

BCR-ABL-transformed GMP as myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Development of an effective therapy for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Jak2 is involved in c-Myc induction by Bcr-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Chronic myeloid leukemia stem cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Multiple myeloma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Primary Bioassay of Human Myeloma Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Wnt signaling promotes reprogramming of somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stemness of B-cell progenitors in multiple myeloma bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Isolation of side population cells in B-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Clinical implication of targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

On the origin of syn- and metachronous urothelial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Role of cancer stem cells in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Progress and pitfalls in the identification of cancer stem cell-targeting therapies in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cells: a new framework for the design of tumor therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Targeting glioma stem cells: a novel framework for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The difficulty of targeting cancer stem cell niches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Stem cells and their niches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Side population and cancer stem cells: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Theragnostic imaging for radiation oncology: dose-painting by numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MicroRNA regulation of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Functional analysis of microRNAs in human hepatocellular cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Nanobiotechnology for the capture and manipulation of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Nanoparticles in oncology: the new theragnostic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Photoacoustic detection of metastatic melanoma cells in the human circulatory system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulating cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Epigenetic regulation in adult stem cells and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Thematic series: Epigenetics in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

Dynamic regulation of cancer stem cells and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2014.958231

10.3109/07357907.2014.958231

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference